A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants
Clinical trial NCT05067439 · COMPLETED
Trial details
- NCT number
- NCT05067439
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2022-02-26
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.